Insmed reported $27.4M in Trade Debtors for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Debtors Change
DBV Technologies DBVT:US USD 8.92M 710K
Acelrx Pharmaceuticals ACRX:US USD 512K 148K
Alimera Sciences ALIM:US USD 19.14M 1.18M
Biomarin Pharmaceutical BMRN:US USD 419.62M 46.88M
Cytokinetics CYTK:US USD 2.29M 321K
Gilead Sciences GILD:US USD 4.78B 423M
Heron Therapeutics HRTX:US USD 42.19M 1.88M
Insmed INSM:US USD 27.4M 2.08M
Mirati Therapeutics MRTX:US USD 1.68M 153K
Novartis NVS:US USD 8.33B 346M
Regeneron Pharmaceuticals REGN:US USD 5.33B 219.6M
Sarepta Therapeutics SRPT:US USD 223.45M 6.82M
Seattle Genetics SGEN:US USD 486.76M 48.71M
Ultragenyx Pharmaceutical RARE:US USD 31.16M 6.04M
Vertex Pharmaceuticals VRTX:US USD 1.39B 52.3M